Brodalumab Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Brodalumab has been used in trials studying the treatment of Asthma, Psoriasis, Crohn's Disease, Psoriatic Arthritis, and Rheumatoid Arthritis. Brodalumab was FDA approved in February, 2017 as Siliq for the treatment of moderate-to-severe plaque psoriasis.

Brodalumab Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Brodalumab Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
TargetMol Chemicals Inc.	+17819995354	marketing@targetmol.com	United States	32371	58
Aladdin Scientific		tp@aladdinsci.com	United States	57505	58
BOC Sciences	1-631-485-4226; 16314854226	info@bocsci.com	United States	12952	65
Shanghai EFE Biological Technology Co., Ltd.	021-65675885 18964387627	info@efebio.com	China	9803	58
Shanghai YuanYe Biotechnology Co., Ltd.	021-61312847; 18021002903	3008007409@qq.com	China	71826	60
Guangzhou Hongyuan Chemical Co.,Ltd	15817493340	981810490@qq.com	China	1566	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10308	58
TargetMol Chemicals Inc.	4008200310	marketing@tsbiochem.com	China	24981	58
Biolab Reagents	18108604356	info@biolabreagent.com	China	9868	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 086-15871494362 13720134139	orders@jknbiochem.com	China	6203	58

---

• Brodalumab
• Research Grade Brodalumab(DHJ38901)
• Brodalumab (anti-IL17RA)
• LP 0160|||KHK-4827|||AMG-827
• Research Grade Brodalumab
• 1174395-19-7